These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9660111)

  • 1. Repeated trimipramine induces dopamine D2/D3 and alpha1-adrenergic up-regulation.
    Maj J; Rogóz Z; Skuza G; Margas W
    J Neural Transm (Vienna); 1998; 105(2-3):329-42. PubMed ID: 9660111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems.
    Maj J; Rogóz Z
    J Neural Transm (Vienna); 1999; 106(2):197-211. PubMed ID: 10226939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of combined treatment with imipramine and amantadine on the behavioral reactivity of central alpha1-adrenergic system in rats.
    Dziedzicka-Wasylewska M; Faron-Górecka A; Rogóz Z; Solich J
    Behav Pharmacol; 2004 Mar; 15(2):159-65. PubMed ID: 15096916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.
    Rogoz Z; Wrobel A; Dlaboga D; Maj J; Dziedzicka-Wasylewska M
    J Physiol Pharmacol; 2002 Mar; 53(1):105-16. PubMed ID: 11939713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of repeated treatment with milnacipran on the central dopaminergic system.
    Rogóz Z; Margas W; Dlaboga D; Góralska M; Dziedzicka-Wasylewska M; Maj J
    Pol J Pharmacol; 2000; 52(2):83-92. PubMed ID: 10949109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of repeated treatment with reboxetine on the central alpha 1-adrenergic and dopaminergic receptors.
    Rogóz Z; Margas W; Skuza G; Solich J; Kuśmider M; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2002; 54(6):593-603. PubMed ID: 12866714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of venlafaxine, a new antidepressant, given acutely.
    Rogóz Z; Dziedzicka-Wasylewska M; Maj J
    Pol J Pharmacol; 1998; 50(2):107-15. PubMed ID: 9798262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some behavioural effects of antidepressant drugs are time-dependent.
    Dziedzicka-Wasylewska M; Rogóz Z; Margas W; Dlaboga D; Góralska M
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):373-93. PubMed ID: 11294483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats.
    Rogóz Z; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2000; 52(5):331-6. PubMed ID: 11334224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of milnacipran, a new antidepressant, given repeatedly on the alpha1-adrenergic and serotonergic 5-HT2A systems.
    Maj J; Rogóz Z; Dlaboga D; Dziedzicka-Wasylewska M
    J Neural Transm (Vienna); 2000; 107(11):1345-59. PubMed ID: 11145008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z
    Eur J Pharmacol; 1998 Jun; 351(1):31-7. PubMed ID: 9698202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of repeated co-treatment with imipramine and metyrapone on the behavioral reactivity of the central serotonin, dopamine and alpha 1-adrenergic systems in rats.
    Rogóz Z
    Pharmacol Rep; 2007; 59(5):588-94. PubMed ID: 18048960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely.
    Rogóz Z; Wróbel A; Krasicka-Domka M; Maj J
    Pol J Pharmacol; 1999; 51(5):399-404. PubMed ID: 10817540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of repeated treatment with tianeptine and fluoxetine on central dopamine D(2) /D(3) receptors.
    Dziedzicka-Wasylewska M; Rogoz Z; Skuza G; Dlaboga D; Maj J
    Behav Pharmacol; 2002 Mar; 13(2):127-38. PubMed ID: 11981225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors.
    Rogóz Z; Wróbel A; Dlaboga D; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2002; 54(4):381-9. PubMed ID: 12523492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roxindole, a potential antidepressant. I. Effect on the dopamine system.
    Maj J; Kolodziejczyk K; Rogóz Z; Skuza G
    J Neural Transm (Vienna); 1996; 103(5):627-41. PubMed ID: 8811507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity.
    D'Aquila PS; Panin F; Castelli MP; Serra G
    Behav Pharmacol; 2006 Mar; 17(2):101-6. PubMed ID: 16495718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of repeated treatment with reboxetine on the central alpha1-adrenergic system.
    Rogóz Z; Kolasiewicz W
    Pol J Pharmacol; 2001; 53(6):663-7. PubMed ID: 11985343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.